Wednesday, July 17, 2013

Compounder Definition In House Bill May Use Blended Metrics

By Derrick Gingery / Email the Author / Jul. 17, 2013 


Executive Summary

FDA and stakeholders reiterate that volume cannot be the sole measure of whether a compounder should be regulated like a drug manufacturer; Rep. Griffith pitches potentially using it and other indicators to draw the line.


Purchase this Article

$50.00   

No comments: